This list is an analysis based on recent market events. It's not an investment recommendation.
About
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
The current price of 4724.TWO is TWD9.03 TWD — it has increased by +0.89% in the past 24 hours. Watch Meribank Biotech stock price performance more closely on the chart.
What is Meribank Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Meribank Biotech stocks are traded under the ticker 4724.TWO.
Is Meribank Biotech stock price growing?▼
4724.TWO stock has risen by +0.11% compared to the previous week, the month change is a -11.9% fall, over the last year Meribank Biotech has showed a -48.55% decrease.
What is Meribank Biotech market cap?▼
Today Meribank Biotech has the market capitalization of 866.66M
What is Meribank Biotech revenue for the last year?▼
Meribank Biotech revenue for the last year amounts to 732.86M TWD.
What is Meribank Biotech net income for the last year?▼
4724.TWO net income for the last year is -189.42M TWD.
How many employees does Meribank Biotech have?▼
As of November 3, 2026, the company has 142 employees.
In which sector is Meribank Biotech located?▼
Meribank Biotech operates in the Health & Wellness sector.
When did Meribank Biotech complete a stock split?▼
Meribank Biotech has not had any recent stock splits.
Where is Meribank Biotech headquartered?▼
Meribank Biotech is headquartered in Taipei City, Taiwan.